Category Archives: Health

Latest From Health

Digital Health in a Mobile World

DigitalHealth-728x90

Healthcare is shaping up to be an important area for all the big technology companies that focus on mobile devices. And that is pretty much all of them. When Sony sold off its VAIO computer division to Japan Industrial Partners earlier this year, among the reasons given were “drastic changes in the global PC industry”, and a need to “concentrate on … smartphones and tablets.” Over at Microsoft, new CEO Satya Nadella says we’ve entered Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Making it Personal

making-it-personal copy

The “valley of death” between drug discovery and the development and provision of therapy is a huge issue in biotech. Recent news, however, highlights valiant entrepreneurs who look at the chasm and are building bridges to cross it. One of these is Ilan Ganot whose son, Eytani, was diagnosed with Duchenne muscular dystrophy (DMD) at the age of two years old. The ex-hedge fund banker at JPMorgan Chase & Co quit his job in London, Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

My Regeneration

brain-scan

What can today’s generation hope for from regenerative medicine? It’s a frontier for business, the medical profession and society. Regenerative medicine aims to shift the focus from palliative care to the development of treatments that address diabetes, Parkinson’s disease, stroke and heart disease. The hope is that we’ll live longer, healthier lives and have greater independence in old age, thereby reducing the burden on healthcare systems. Given global population demographics, this is essential: according to the World Health Organisation by Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , ,

Ensuring the Safety and Commercial Success of Biosimilars in the United States

attendees

The forthcoming arrival of biosimilars into the U.S has spurred debate over the approaches that the FDA and industry should take to ensure patient safety while promoting market competition and continued biomedical innovation. During a presentation Tuesday at the 2014 BIO International Convention, participants at this Super Session focused on the need for prescribing physicians and providers to closely partners with one another to ensure that safety and efficacy are the priorities in the debate Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Fighting Prostate Cancer with Immunotherapy

shutterstock_27291016

Advaxis and UC San Francisco join forces to develop and test a range of novel constructs Prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. According to the American Cancer Society, around 230,000 new cases of prostate cancer are diagnosed and 30,000 men die from the disease each year. Cancer immunotherapy offers one promising approach to combating the disease. The University of California, San Francisco, (UCSF) and biotechnology Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,